ICI’s NOLVADEX (TAMOXIFEN) SHOULD BE INDICATED FOR ADVANCED MALE BREAST CANCER BUT NOT AS ADJUVANT THERAPY IN MEN, ONCOLOGICS ADVISORY CMTE. CONCLUDES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".